Recently, we demonstrated that tuftsin-derived T-peptide had potential effect on adaptive immunity in sepsis, such as lowering the suppressive ability of CD4+CD25+ Tregs on CD4+CD25− T cells [31]. This evidence concerns the gene CD4 and Sepsis.